Stargardt Disease
Ophthalmology·MeSH: Stargardt Disease
Prevalence
30.0 / 100K
7 drugs in development·7 companies·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| zimura | IVERIC bio, Inc. (ISEE) |
Phase 2(2)
Preclinical(3)
Phase 2/Phase 3(1)
| Drug | Company |
|---|---|
| ocu410st | Ocugen, Inc. (OCGN) |
Compare drugs
Frequently asked questions
How many drugs are in development for Stargardt Disease?
BioSniper tracks 7 drugs in development for Stargardt Disease across 7 companies.
How many clinical trials target Stargardt Disease?
There are 1 clinical trial targeting Stargardt Disease tracked by BioSniper.
What is the prevalence of Stargardt Disease?
The estimated prevalence of Stargardt Disease is approximately 30.0 per 100,000 population.
Deep-dive into Stargardt Disease
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis